Compounds > fullerene c60
Page last updated: 2024-09-03

fullerene c60 and 8,11,14-eicosatrienoic acid

fullerene c60 has been researched along with 8,11,14-eicosatrienoic acid in 1 studies

Compound Research Comparison

Studies
(fullerene c60)		Trials
(fullerene c60)		Recent Studies (post-2010)
(fullerene c60)		Studies
(8,11,14-eicosatrienoic acid)		Trials
(8,11,14-eicosatrienoic acid)		Recent Studies (post-2010) (8,11,14-eicosatrienoic acid)
3,80652,1701,47835424

Protein Interaction Comparison

ProteinTaxonomyfullerene c60 (IC50)8,11,14-eicosatrienoic acid (IC50)
Oxoeicosanoid receptor 1Homo sapiens (human)2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbour, S; Chalfant, C; Conrad, DH; Dellinger, A; Kepley, CL; Norton, SK; Sturgill, J; Wijesinghe, DS; Zhou, Z1

Other Studies

1 other study(ies) available for fullerene c60 and 8,11,14-eicosatrienoic acid

ArticleYear
Epoxyeicosatrienoic acids are involved in the C(70) fullerene derivative-induced control of allergic asthma.
    The Journal of allergy and clinical immunology, 2012, Volume: 130, Issue:3

    Topics: 8,11,14-Eicosatrienoic Acid; Animals; Asthma; Bronchoconstriction; Eosinophilia; Female; Fullerenes; Immunoglobulin E; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL

2012